Palivizumab
CAS No. : 188039-54-5
(Synonyms: MEDI 493)
| Size | Price | Stock |
|---|---|---|
| 1mg | $280 | In-stock |
| 5mg | $700 | In-stock |
| 10mg | $1100 | In-stock |
| 25mg | $2050 | In-stock |
| 50mg | $3250 | In-stock |
| 100mg | $5000 | In-stock |
| 200 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-P9944 |
| M.Wt: | 1000.00 |
| Formula: | N/A |
| Purity: | >98 % |
| Solubility: | H2O |
Palivizumab (MEDI 493) is a humanized monoclonal antibody against respiratory syncytial virus (RSV). Palivizumab can bind to RSV F protein with a Kd value of 1.4 nM. Palivizumab can prevent respiratory syncytial virus infection in cotton mice[1]. IC50 & Target:RSV-F In Vitro: Palivizumab has RSV neutralizing activity and an EC50 value of 0.95850 nM with IgG1 protein[2]. In Vivo: Palivizumab (0.625-5 mg/kg (i.m.) or 0.312-10 mg/kg (i.v.); single dose) can prevent respiratory syncytial virus infection in cotton mice[1]. Palivizumab (0.05 mg/kg; single dose; intranasally administered)can prevent RSV infection in mice[2]. Palivizumab (15 mg/kg; single dose; s.c.) can inhibit RSV induced airway neurogenic inflammation in rats[3].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information- Product Name:
- Palivizumab
- Cat. No.:
- HY-P9944
- Quantity:
Your information is safe with us.